All
1.
IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
Marieke L Kuijjer, Elisabeth FP Peterse, Brendy EWM van den Akker, Inge H Briaire-de Bruijn, Massimo Serra, Leonardo A Meza-Zepeda, Ola Myklebost, A Bassim Hassan, Pancras CW Hogendoorn, Anne-Marie Cleton-Jansen BMC Cancer 2013, 13 :245 (20 May 2013)
Abstract | Provisional PDF
2.
Equol enhances tamoxifen's anti-tumor activity by induction of caspase-mediated apoptosis in MCF-7 breast cancer cells
Christiana Charalambous, Chara A Pitta, Andreas I Constantinou BMC Cancer 2013, 13 :238 (15 May 2013)
Abstract | Provisional PDF
| PubMed
3.
Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells
Mamoru Tanaka, Hiromi Kataoka, Shigenobu Yano, Hiromi Ohi, Keisuke Kawamoto, Takashi Shibahara, Tsutomu Mizoshita, Yoshinori Mori, Satoshi Tanida, Takeshi Kamiya, Takashi Joh BMC Cancer 2013, 13 :237 (14 May 2013)
Abstract | Full text | PDF
| PubMed
4.
Chronic inhibition of tumor cell-derived VEGF enhances the malignant phenotype of colorectal cancer cells
Naoko Yamagishi, Shigetada Teshima-Kondo, Kiyoshi Masuda, Kensei Nishida, Yuki Kuwano, Duyen T Dang, Long H Dang, Takeshi Nikawa, Kazuhito Rokutan BMC Cancer 2013, 13 :229 (7 May 2013)
Abstract | Full text | PDF
| PubMed
5.
Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-β
Jun Ohishi, Mikiko Aoki, Kazuki Nabeshima, Junji Suzumiya, Tamotsu Takeuchi, Akira Ogose, Michiyuki Hakozaki, Yuichi Yamashita, Hiroshi Iwasaki BMC Cancer 2013, 13 :224 (4 May 2013)
Abstract | Full text | PDF
| ePUB | PubMed
6.
Evaluation of hypoxia in a feline model of head and neck cancer using 64Cu-ATSM positron emission tomography/computed tomography
Elizabeth A Ballegeer, Nicole J Madrill, Kevin L Berger, Dalen W Agnew, Elizabeth A McNiel BMC Cancer 2013, 13 :218 (30 April 2013)
Abstract | Provisional PDF
| PubMed
7.
Evidence for tankyrases as antineoplastic targets in lung cancer
Alexander M Busch, Kevin C Johnson, Radu V Stan, Aarti Sanglikar, Yashi Ahmed, Ethan Dmitrovsky, Sarah J Freemantle BMC Cancer 2013, 13 :211 (28 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
8.
In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells
Drazen B Zimonjic, Lai N Chan, Veenu Tripathi, Jie Lu, Ohyun Kwon, Nicholas C Popescu, Douglas R Lowy, Fuyuhiko Tamanoi BMC Cancer 2013, 13 :198 (22 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
9.
A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy
Tracy R Daniels-Wells, Gustavo Helguera, Richard K Leuchter, Rafaela Quintero, Maggie Kozman, José A Rodríguez, Elizabeth Ortiz-Sánchez, Otoniel Martínez-Maza, Birgit C Schultes, Christopher F Nicodemus, Manuel L Penichet BMC Cancer 2013, 13 :195 (17 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
10.
Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer
Michele T Yip-Schneider, Huangbing Wu, Keith Stantz, Narasimhan Agaram, Peter A Crooks, C Max Schmidt BMC Cancer 2013, 13 :194 (17 April 2013)
Abstract | Provisional PDF
| PubMed
